Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Healthcare providers follow a systematic approach to diagnose gastrointestinal bleeding: Complete medical history - Discussing symptoms, medications, and risk factors Physical examination - Checking vital signs, skin colour, and abdominal tenderness Laboratory tests - Measuring blood count, clotting function, and liver enzymes Imaging studies - Imaging studies such as CT angiography are often used to detect active bleeding when endoscopy is inconclusive Endoscopic procedures - Direct visualisation of the digestive tract Tests Used to Diagnose Gastrointestinal (GI) Bleeding Modern diagnostic techniques for identifying GI bleed sources include: Upper endoscopy - examining the oesophagus, stomach, and duodenum Colonoscopy - visualising the entire colon and rectum Capsule endoscopy - swallowing a tiny camera to examine the small intestines CT angiography - imaging active bleeding sites Tagged red blood cell scans - tracking bleeding using radioactive markers Blood tests - assessing anaemia severity and clotting disorders Treatment for Gastrointestinal Bleeding Gastrointestinal bleeding treatment depends on the bleeding source, severity, and underlying cause: Emergency stabilisation - IV fluids and blood transfusions for severe cases Endoscopic interventions - cautery, injection therapy, or clip placement Medications - proton pump inhibitors for ulcers, antibiotics for infections Surgical procedures - reserved for cases where other treatments fail Management of underlying conditions - treating inflammatory bowel diseases or liver disease Prevention of Gastrointestinal Bleeding Preventing gastrointestinal bleeding involves addressing modifiable risk factors: Use NSAIDs cautiously , especially if you have ulcer risk factors Treat H
When GLP-1 medications are appropriate, our providers will issue prescriptions for the commercially available versions, which patients can fill at their local pharmacy
Recently, two randomized controlled trials (RCTs) demonstrated that tirzepatide, a dual GLP-1/GIP receptor agonists, reduced the AHI and hypoxic burden, and improved sleep-related patient-reported outcomes among individuals with moderate-to-severe OSA [24]
Blood pressure also improved, with systolic blood pressure falling about 2.5 mm Hg and diastolic pressure about 1.5 mm Hg
